Mangoceuticals (MGRX) Share-based Compensation (2023 - 2026)
Mangoceuticals' (MGRX) quarterly Share-based Compensation came in at $37978.0 in Q1 2026, down 98.04% year-on-year from $1.9 million in Q1 2025, and up 213.47% quarter-over-quarter from -$33471.0 in Q4 2025.
Mangoceuticals (MGRX) Share-based Compensation (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed Share-based Compensation across 4 years of filings, most recently posting $37978.0 for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $37978.0, down 98.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$732242.0 (down 118.27% YoY), and the FY2025 annual result was $1.2 million, down 44.53% from the prior year.
- Share-based Compensation came in at $37978.0 for Q1 2026 at Mangoceuticals, up from -$33471.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.2 million in Q2 2025 to a low of -$3.9 million in Q3 2025.
- The 4-year median for Share-based Compensation is $64271.0 (2023), against an average of $302845.1.
- Peak annual rise in Share-based Compensation reached 6128.11% in 2025, while the deepest fall reached 345.32% in 2025.
- Mangoceuticals' Share-based Compensation stood at -$547287.0 in 2023, then soared by 177.24% to $422750.0 in 2024, then slumped by 107.92% to -$33471.0 in 2025, then jumped by 213.47% to $37978.0 in 2026.
- The last three Share-based Compensation figures came in at $37978.0 (Q1 2026), -$33471.0 (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 119.26 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.68 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 19.41 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 11.69 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 22.64 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 36.74 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 11.45 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 21.92 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 9.50 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | 37,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,978.00 |
| Mar 31, 2026 | 37,978.00 |
| Dec 31, 2025 | -33,471.00 |
| Dec 31, 2025 | -33,471.00 |
| Sep 30, 2025 | -3.91 Mn |
| Sep 30, 2025 | -3.91 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | 422,750.00 |
| Dec 31, 2024 | 422,750.00 |
| Sep 30, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 50,980.00 |
| Jun 30, 2024 | 50,980.00 |
| Mar 31, 2024 | 37,965.00 |
| Mar 31, 2024 | 37,965.00 |
| Dec 31, 2023 | -547,287.00 |
| Dec 31, 2023 | -547,287.00 |